Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | PHAR | EVER |
|---|---|---|
| Price | $9.65 | $19.39 |
| Change today | ▼ 0.31% | ▲ 0.00% |
| Market cap | $683.01M | $683.30M |
| Return, 3 months | -31.3% | -21.7% |
| Return, year to date | -45.4% | -28.2% |
| Return, 1 year | -32.8% | -12.9% |
| P/E (TTM) | 68.9 | 6.3 |
| P/B | 2.5 | 2.7 |
| P/E percentile vs own 5y | 91st | 66th |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | -3.2% | +24.6% |
| Net profit growth (YoY) | -64.0% | +30.5% |
| Gross margin | 86.5% | 97.6% |
| Operating margin | 3.8% | 11.0% |
| Net margin | 2.5% | 15.2% |
| Return on equity | 3.6% | 53.6% |
| Analyst target vs. price | +288.6% | +52.1% |
| Analyst buy share | 100% | 86% |
| RSI (14) | 33 | 36 |
| 30-day volatility | 38.4% | 66.8% |
| Max drawdown, 1 year | -54.4% | -48.8% |
| Trend read | Strong downtrend | Leaning bearish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
